Altrinsic Global Advisors Has Cut Biomarin Pharmaceutical (BMRN) Position By $1.64 Million; Big Yellow Group plc (LON:BYG) Had 7 Analysts Last Week

June 20, 2017 - By Nellie Frank

Altrinsic Global Advisors Llc decreased Biomarin Pharmaceutical Inc (BMRN) stake by 28.5% reported in 2016Q4 SEC filing. Altrinsic Global Advisors Llc sold 20,000 shares as Biomarin Pharmaceutical Inc (BMRN)’s stock declined 0.71%. The Altrinsic Global Advisors Llc holds 50,168 shares with $4.16 million value, down from 70,168 last quarter. Biomarin Pharmaceutical Inc now has $16.59 billion valuation. The stock rose 0.84% or $0.77 reaching $92.12. About 705,836 shares traded. BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) has risen 5.29% since June 20, 2016 and is uptrending. It has underperformed by 11.41% the S&P500.

Among 13 analysts covering Big Yellow Group (LON:BYG), 7 have Buy rating, 1 Sell and 5 Hold. Therefore 54% are positive. Big Yellow Group had 83 analyst reports since August 4, 2015 according to SRatingsIntel. The rating was maintained by Jefferies with “Buy” on Wednesday, November 23. The firm has “Overweight” rating given on Tuesday, September 1 by JP Morgan. The company was maintained on Thursday, April 21 by Jefferies. The firm earned “Hold” rating on Wednesday, February 17 by Liberum Capital. JP Morgan maintained Big Yellow Group plc (LON:BYG) rating on Thursday, May 12. JP Morgan has “Neutral” rating and GBX 850 target. JP Morgan maintained the shares of BYG in report on Tuesday, September 6 with “Underweight” rating. Stifel Nicolaus maintained the stock with “Buy” rating in Tuesday, October 13 report. The rating was maintained by Liberum Capital on Monday, March 13 with “Buy”. The rating was maintained by Peel Hunt with “Hold” on Wednesday, October 26. The rating was downgraded by JP Morgan on Wednesday, December 16 to “Neutral”. See Big Yellow Group plc (LON:BYG) latest ratings:

15/06/2017 Broker: Goldman Sachs Rating: Buy New Target: GBX 946.00 Maintain
05/06/2017 Broker: JP Morgan Rating: Overweight Old Target: GBX 880.00 New Target: GBX 880.00 Maintain
31/05/2017 Broker: JP Morgan Rating: Overweight Maintain
24/05/2017 Broker: Jefferies Rating: Hold Old Target: GBX 740.00 New Target: GBX 725.00 Maintain
24/05/2017 Broker: JP Morgan Rating: Overweight Old Target: GBX 820.00 New Target: GBX 820.00 Maintain
24/05/2017 Broker: Goldman Sachs Rating: Buy New Target: GBX 960.00 Maintain
23/05/2017 Broker: Numis Securities Rating: Add Old Target: GBX 808.00 New Target: GBX 808.00 Maintain
23/05/2017 Broker: Peel Hunt Rating: Hold Old Target: GBX 675.00 New Target: GBX 700.00 Maintain
23/05/2017 Broker: Liberum Capital Rating: Buy Old Target: GBX 800.00 New Target: GBX 800.00 Maintain
26/04/2017 Broker: Jefferies Rating: Buy Old Target: GBX 740.00 New Target: GBX 740.00 Maintain

Big Yellow Group PLC is a United Kingdom company, which is engaged in the provision of self-storage and related services. The company has market cap of 1.27 billion GBP. The Firm operates from a platform of approximately 89 stores, including 16 stores branded as Armadillo Self Storage. It has a 12.84 P/E ratio. The Firm also owns over seven Big Yellow self-storage development sites , of which two have planning consent.

The stock decreased 0.43% or GBX 3.5 on June 20, reaching GBX 807. About 142,998 shares traded. Big Yellow Group plc (LON:BYG) has 0.00% since June 20, 2016 and is . It has underperformed by 16.70% the S&P500.

Since January 6, 2017, it had 0 insider purchases, and 27 insider sales for $16.87 million activity. 11,000 BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) shares with value of $996,530 were sold by BIENAIME JEAN JACQUES. SPIEGELMAN DANIEL K sold $214,916 worth of stock or 2,303 shares. Ajer Jeffrey Robert sold $89,968 worth of stock. $862,230 worth of stock was sold by Davis George Eric on Monday, June 5. $712,500 worth of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) was sold by LAWLIS V BRYAN on Wednesday, March 1. The insider Mueller Brian sold 7,482 shares worth $687,334.

Altrinsic Global Advisors Llc increased Telefonica Brasil Sa stake by 90,350 shares to 155,502 valued at $2.08M in 2016Q4. It also upped Alnylam Pharmaceuticals Inc (NASDAQ:ALNY) stake by 30,000 shares and now owns 102,700 shares. Taiwan Semiconductor Mfg Ltd (NYSE:TSM) was raised too.

Among 20 analysts covering BioMarin Pharmaceutical (NASDAQ:BMRN), 13 have Buy rating, 0 Sell and 7 Hold. Therefore 65% are positive. BioMarin Pharmaceutical had 43 analyst reports since August 5, 2015 according to SRatingsIntel. The firm has “Buy” rating by William Blair given on Wednesday, August 5. Wedbush maintained the stock with “Neutral” rating in Monday, October 5 report. The company was maintained on Wednesday, May 31 by Jefferies. Morgan Stanley initiated it with “Overweight” rating and $110 target in Tuesday, February 7 report. The firm has “Outperform” rating given on Friday, February 26 by RBC Capital Markets. The stock of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) has “Outperform” rating given on Tuesday, March 22 by Credit Suisse. As per Monday, August 24, the company rating was maintained by RBC Capital Markets. PiperJaffray downgraded the shares of BMRN in report on Monday, November 7 to “Neutral” rating. The firm has “Overweight” rating given on Friday, February 26 by Barclays Capital. The stock of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) earned “Neutral” rating by Piper Jaffray on Monday, November 7.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: